Genmab A/S (ETR:GE9)

Genmab had revenue of $925.00M USD in the quarter ending June 30, 2025, with 18.74% growth. This brings the company's revenue in the last twelve months to $3.65B, up 32.97% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

• Revenue (ttm): $3.65B
• Revenue Growth: +32.97%
• P/S Ratio: 5.43
• Revenue / Employee: $1.36M
• Employees: 2,682
• Market Cap: 16.85B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.99B	545.24M	22.32%
Dec 31, 2023	2.44B	358.99M	17.23%
Dec 31, 2022	2.08B	796.62M	61.88%
Dec 31, 2021	1.29B	-374.23M	-22.52%
Dec 31, 2020	1.66B	855.79M	106.20%